Epigenetic dysregulation is now a hallmark of several complex pathologies, including cancer, metabolic disorders, cardiovascular and neurological diseases.
Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention.
Related Journals of Impact of Epigenetics on Precision Treatment and Medicine
Translational Medicine, Journal of Forensic Research, Emergency Medicine: Open Access, European Journal of Human Genetics, American Journal of Medical Genetics, Journal of Medical Genetics, Journal of Cancer Epigenetics, Human Molecular Genetics, Genetics in Medicine, Journal of Medical Genetics, Circulation: Cardiovascular Genetics, Genetic Epidemiology, European Journal of Human Genetics,Current Protocols in Human Genetics, Pharmacogenetics and Genomics, Twin Research and Human Genetics, Journal of Human Genetics, Human gene therapy methods and BMC Genetics.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : August 18, 2019